For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Prometheus Biosciences, Inc.

USPTO Granted Patents = 14

EPO Patents = 7

Trademarks = 22

Forward Citations = 28

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Cindy T Dickerson (5 out of 5 patents)

Janine Bilsborough (5 out of 6 patents)

Jeffry Dean Watkins (5 out of 103 patents)

4. Stephan R Targan (4 out of 50 patents)

5. Patricia McNeeley (3 out of 4 patents)

6. Bradley Henkle (3 out of 4 patents)

7. Dalin Li (3 out of 9 patents)

8. Laurens Kruidenier (3 out of 3 patents)

9. Mahyar Sabripour (3 out of 3 patents)

10. Dermot P Mcgovern (3 out of 6 patents)

11. Robert Higuchi (2 out of 20 patents)

12. Sharat Singh (2 out of 95 patents)

13. Janine M Bilsborough (2 out of 54 patents)

14. Rafael Rojas (2 out of 2 patents)

15. Matthew Reissman (2 out of 2 patents)

14 patents: Sort by Forward Citations

1. 12391752 - Methods of enriching or amplifying nucleic acids in a sample from a patient with inflammatory bowel disease (2025-08-19),

2. 12305236 - Methods and systems for selection and treatment of patients with inflammatory diseases (2025-05-20),

3. 12215147 - Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibody (2025-02-04),

4. 11999789 - Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof (2024-06-04),

5. 11866505 - Anti-CD30L antibodies and uses thereof (2024-01-09),

6. 11773101 - GPR35 modulators (2023-10-03),

7. 11440954 - Optimized anti-TL1A antibodies (2022-09-13),

8. 11292848 - Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof (2022-04-05),

9. 11162943 - Methods for assessing mucosal healing in Crohn's disease patients (2021-11-02),

10. 11136386 - Methods of treating Crohn's disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A) (2021-10-05),

11. 11053251 - GPR35 modulators (2021-07-06),

12. 10794906 - Assays for detecting neutralizing autoantibodies to biologic therapy (2020-10-06),

13. 10697961 - Methods for predicting post-operative recurrence of Crohn's disease (2020-06-30),

14. 10689439 - Optimized anti-TL1A antibodies (2020-06-23),

Prometheus Biosciences, Inc. is a biotechnology company focused on developing precision therapies for patients with inflammatory bowel disease. Through advanced research and innovative technologies, we aim to improve patient outcomes and quality of life. Our team of experts is dedicated to delivering personalized treatments and revolutionizing the field of biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

14 Patents

#367 in San Diego, CA

#5,143 in California

#21,588 in US

#40,857 in the World

San Diego, CA, United States of America

Prometheus Biosciences, Inc.

Forward Citations = 28

37 inventors:

Cindy T Dickerson (5 out of 5 patents)

Janine Bilsborough (5 out of 6 patents)

Jeffry Dean Watkins (5 out of 103 patents)

4. Stephan R Targan (4 out of 50 patents)

5. Patricia McNeeley (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…